Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX4OEU
|
||||
| Drug Name |
(S)-3,3-dimethyl-1-(4-(4-(trifluoromethyl)phenyl)-1H-pyrazol-1-yl)butan-2-yl(S)-1-(1H-pyrazol-5-ylamino)-1,2-dioxoheptan-3-ylcarbamate
|
||||
| Synonyms |
CHEMBL190053
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H33F3N6O4
|
||||
| Canonical SMILES |
CCCC[C@H](NC(=O)O[C@H](Cn1cc(cn1)c2ccc(cc2)C(F)(F)F)C(C)(C)C)C(=O)C(=O)Nc3ccn[nH]3
|
||||
| InChI |
InChI=1S/C27H33F3N6O4/c1-5-6-7-20(23(37)24(38)34-22-12-13-31-35-22)33-25(39)40-21(26(2,3)4)16-36-15-18(14-32-36)17-8-10-19(11-9-17)27(28,29)30/h8-15,20-21H,5-7,16H2,1-4H3,(H,33,39)(H2,31,34,35,38)/t20-,21+/m0/s1
|
||||
| InChIKey |
KXZLSPLTNDGSNP-LEWJYISDSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin B | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| WikiPathways | RANKL/RANK Signaling Pathway | ||||
| Osteoclast Signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.